By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Seahorse Bioscience announced today that In Vitro Technologies is the new distributor of its Seahorse XF Analyzers and consumables in Australia and New Zealand.
Financial and other terms were not disclosed.
Registering provides access to this and other free content.
Already have an account?Login Now.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.